<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04048057</url>
  </required_header>
  <id_info>
    <org_study_id>KMSU-Exercise</org_study_id>
    <nct_id>NCT04048057</nct_id>
  </id_info>
  <brief_title>The Effect of Different Exercise Programs in Coronary Artery Patients: A Randomized Controlled Study</brief_title>
  <official_title>The Effect of Different Exercise Programs in Coronary Artery Patients: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kutahya Medical Sciences University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kutahya Medical Sciences University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are studies showing the superiority of HIIT protocols in patients with CAD in the
      literature, however there is no consensus on the use of HIIT protocols in CAD patients. In
      addition, in these studies, the HIIT protocols differ in severity and duration and there is
      no optimal HIIT protocol. Therefore, this study was planed to investigate of two different
      HIIT protocols and one MICT protocols, which are more commonly used in patients with CAD in
      the literature on exercise capacity, quality of life, body composition, physical activity
      level and fear of movement.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>exercise capacity</measure>
    <time_frame>15 minutes</time_frame>
    <description>Cardiopulmonary exercise test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MacNew Health Related Quallity of Life Qustionnaire</measure>
    <time_frame>15 minutes</time_frame>
    <description>The validity and reliability of the MacNew Heart Disease Health-Related Quality of Life Questionnaire Da≈ükapan et al. in 2008. It is a scale developed to determine the quality of life in heart diseases consisting of 27 items each containing a 7-point Likert type response. In the evaluation of the scale, 3 sub-dimensions (emotional, physical and social) and total score values are used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>1 minute</time_frame>
    <description>Tanita</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity level</measure>
    <time_frame>15 minutes</time_frame>
    <description>International Physical Activity Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fear of movement</measure>
    <time_frame>15 minutes</time_frame>
    <description>Tampa</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Exercise</condition>
  <condition>Cardiac Rehabilitation</condition>
  <arm_group>
    <arm_group_label>Modarete Intensity Continous Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High Intensity Interval Training I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High Intensity Interval Training II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Modarete Intensity Continous Training: Medium intensity continuous exercise training will be performed. Exercise intensity will be adjusted as 50-70% of maximal power.
High Intensity Interval Training I: It will be four cycles consisting of 4 minute high intensity exercise phase and 3 minute active recovery phase. High intensity phase will be adjusted as 85-100% of maximal power and active recovery phase as 50-70% of maximal power.
High Intensity Interval Training II: It will be 10 cycles consisting of 1 minute high intensity exercise phase and 1 minute active recovery phase. High intensity phase will be adjusted as 85-100% of maximal power and active recovery phase as 50-70% of maximal power.</description>
    <arm_group_label>High Intensity Interval Training I</arm_group_label>
    <arm_group_label>High Intensity Interval Training II</arm_group_label>
    <arm_group_label>Modarete Intensity Continous Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have undergone percutaneous transluminal coronary angioplasty or coronary artery
             bypass graft surgery,

          -  Nonobstructive CAD registered by angiography

          -  Left ventricular ejection fraction above 50%,

          -  Clinically stable for more than 2 weeks in terms of symptoms and medical treatment.

        Exclusion Criteria:

          -  Ischemia symptoms,

          -  Being in Class III-IV according to the New York Heart Classification,

          -  Obtaining significant left ventricular outflow obstruction,

          -  Ventricular arrhythmia,

          -  Being marked valvular heart disease,

          -  Failure to comply with exercise testing and training rules,

          -  To have significant orthopedic or neurological comorbidity that prevents full
             participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kutahya Health Sciences University</name>
      <address>
        <city>Kutahya</city>
        <state>Center</state>
        <zip>43100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ismail Okur</last_name>
      <phone>+905552436726</phone>
      <email>fzt.ismailokur@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 5, 2019</study_first_submitted>
  <study_first_submitted_qc>August 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2019</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kutahya Medical Sciences University</investigator_affiliation>
    <investigator_full_name>Ismail Okur</investigator_full_name>
    <investigator_title>Kutahya Medical Sciences University</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

